Medtronic plc (NYSE:MDT) is included among the 14 Quality Stocks with Highest Dividends.

On March 10, Medtronic plc (NYSE:MDT) announced that it had agreed to acquire Scientia Vascular for about $550 million, with additional payments tied to future milestones.

Scientia is a private company based in Utah. It has developed specialized guidewires and catheters that help doctors move through complex brain blood vessels more easily. The technology is built to work alongside Medtronic’s existing neurovascular products. The deal is meant to strengthen Medtronic’s position in stroke and other neurovascular procedures. In these cases, doctors need fast and precise access to blocked or damaged vessels. That part is critical.

Linnea Burman, senior vice president and president of Medtronic’s Neurovascular business, which is part of the Neuroscience Portfolio at Medtronic, made the following comment:

“Medtronic is thrilled to acquire Scientia to accelerate meaningful innovation in neurovascular care. This acquisition positions Medtronic with a full suite of products. It builds a strong foundation for Medtronic and supports procedures across both hemorrhagic and acute ischemic stroke. Medtronic’s best-in-class therapies, combined with Scientia’s leading access portfolio, will be incredibly powerful. With 12 million people globally suffering from stroke each year, we look forward to contributing to better patient outcomes around the world.”

Brain vessels are complicated, and reaching the right spot can take time. Scientia’s tools are designed to improve navigation. This can make procedures faster and more efficient, which may help improve patient outcomes. The acquisition is expected to close in the first half of FY27, subject to regulatory approvals and other closing conditions. It is expected to be minimally dilutive to Medtronic adjusted EPS in FY27 and accretive thereafter.

Medtronic plc (NYSE:MDT) is based in Ireland and provides healthcare technology solutions.

While we acknowledge the potential of MDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading into 2026 and 15 Best Safe Dividend Stocks for 2026

Disclosure: None. Follow Insider Monkey on Google News.